StockDrifts LogoStockDrifts

Sabby Management 13F Portfolio ยท Hal Mintz

Portfolio Manager
Hal Mintz
Performance
-1.22% (2026 Q2)
AUM (13F)
$110.52M
# of Holdings
16
Performance Rank
Allocation (Top 20)
92.64%
Latest filing
Q2 2026

Sabby Management LLC Holdings Map

Top 12 Sabby Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
SPY
STATE STREET SPDR S&P
34.17%5.5K$4.1M
+101.17%(+2.77K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 335 shares2026-Q1: 2.7K shares2026-Q2: 5.5K shares
$661.53(+17.59%)
2026-06-30
TOYO
TOYO CO LTD
29.13%503.8K$3.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 503.8K shares
$7.18(-21.22%)
2026-06-30
FAMI
FARMMI INC
6.99%3.52M$840Knew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 3.52M shares
$0.74(-82.55%)
2026-06-30
CRVO
CERVOMED INC
6.42%248.9K$772Knew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 248.9K shares
$3.36(-12.80%)
2026-06-30
TPST
TEMPEST THERAPEUTICS INC
4.72%511.3K$568K
+2763.38%(+493.43K)
2025-Q2: 276.6K shares2025-Q3: 0 shares2025-Q4: 178.6K shares2026-Q1: 17.9K shares2026-Q2: 511.3K shares
$1.56(-25.15%)
2026-06-30
BIAF
BIOAFFINITY TECHNOLOGIES
2.47%365.6K$297Knew2025-Q2: 0 shares2025-Q3: 242.8K shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 365.6K shares
$2.70(-85.80%)
2026-06-30
BCTX
BRIACELL THERAPEUTICS CORP
2.18%80.7K$262K
+9.21%(+6.81K)
2025-Q2: 4.0K shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 73.9K shares2026-Q2: 80.7K shares
$7.50(-54.11%)
2026-06-30
REVB
REVELATION BIOSCIENCES INC
1.8%210.6K$217K
+111.78%(+111.15K)
2025-Q2: 5.5K shares2025-Q3: 51.8K shares2025-Q4: 151.4K shares2026-Q1: 99.4K shares2026-Q2: 210.6K shares
$6.47(-82.84%)
2026-06-30
SNES
SENESTECH INC
1.76%141.8K$211K
-35.13%(-76.78K)
2025-Q2: 0 shares2025-Q3: 71.3K shares2025-Q4: 210.6K shares2026-Q1: 218.5K shares2026-Q2: 141.8K shares
$3.57(-64.82%)
2026-06-30
BCTXL
BRIACELL THERAPEUTICS CORP
1.41%190.4K$169K
-49.99%(-190.30K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 380.7K shares2026-Q2: 190.4K shares
$1.03(-19.91%)
2026-06-30

About Sabby Management LLCโ€™s portfolio

Sabby Management LLC reports $110.52M in US-listed equity holdings across 16 positions in its most recent 13F filing. Its largest disclosed positions are SPY (34.2%), TOYO (29.1%) and FAMI (7.0%). The top 20 holdings account for 92.64% of reported assets. Its disclosed equity book has returned -81.05% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
SPY โ€” 36.9% ($4.11M)TOYO โ€” 31.4% ($3.50M)FAMI โ€” 7.5% ($840.3K)CRVO โ€” 6.9% ($771.5K)TPST โ€” 5.1% ($567.5K)BIAF โ€” 2.7% ($296.9K)BCTX โ€” 2.3% ($261.5K)REVB โ€” 1.9% ($216.9K)SNES โ€” 1.9% ($211.2K)BCTXL โ€” 1.5% ($169.4K)Other โ€” 1.7% ($191.6K)
98%in top 10
  • SPY36.9%
  • TOYO31.4%
  • FAMI7.5%
  • CRVO6.9%
  • TPST5.1%
  • BIAF2.7%
  • BCTX2.3%
  • REVB1.9%
  • SNES1.9%
  • BCTXL1.5%
  • Other1.7%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
5
TOYOTOYO CO LTD29.1%
FAMIFARMMI INC7.0%
CRVOCERVOMED INC6.4%
BIAFBIOAFFINITY TECHNOLOGIES2.5%
+1 opened
Added to
4
SPYSTATE STREET SPDR S&P+101.2%
TPSTTEMPEST THERAPEUTICS INC+2763.4%
REVBREVELATION BIOSCIENCES INC+111.8%
BCTXBRIACELL THERAPEUTICS CORP+9.2%
Trimmed
3
INMINMED PHARMACEUTICALS-79.6%
BCTXLBRIACELL THERAPEUTICS CORP-50.0%
SNESSENESTECH INC-35.1%

Unlock alerts, watchlists & AI chat

Sign up free to track Sabby Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Sabby Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1535610). View Sabby Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all